National Academies Press: OpenBook

Criteria for Selecting the Leading Health Indicators for Healthy People 2030 (2019)

Chapter: Appendix C Committee Member Biosketches

« Previous: Appendix B Meeting Agendas
Suggested Citation:"Appendix C Committee Member Biosketches." National Academies of Sciences, Engineering, and Medicine. 2019. Criteria for Selecting the Leading Health Indicators for Healthy People 2030. Washington, DC: The National Academies Press. doi: 10.17226/25531.
×
Page 31
Suggested Citation:"Appendix C Committee Member Biosketches." National Academies of Sciences, Engineering, and Medicine. 2019. Criteria for Selecting the Leading Health Indicators for Healthy People 2030. Washington, DC: The National Academies Press. doi: 10.17226/25531.
×
Page 32
Suggested Citation:"Appendix C Committee Member Biosketches." National Academies of Sciences, Engineering, and Medicine. 2019. Criteria for Selecting the Leading Health Indicators for Healthy People 2030. Washington, DC: The National Academies Press. doi: 10.17226/25531.
×
Page 33
Suggested Citation:"Appendix C Committee Member Biosketches." National Academies of Sciences, Engineering, and Medicine. 2019. Criteria for Selecting the Leading Health Indicators for Healthy People 2030. Washington, DC: The National Academies Press. doi: 10.17226/25531.
×
Page 34

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix C Committee Member Biosketches1 George J. Isham, M.D., M.S. (Chair), is currently a Senior Fellow at the HealthPartners Institute in Minneapolis, Minnesota. His areas of interest include understanding how health is created in populations and how to improve health and health care quality and financing. He is formerly a Senior Advisor (2012–2017) and Medical Director and Chief Health Officer (1993– 2012) at HealthPartners. He is also currently a Senior Advisor to the Alliance of Community Health Plans and a member of the advisory board for the Center for Health Economics and Policy at FTI Consulting. Dr. Isham is an elected member of the National Academy of Medicine and was designated as a National Associate of the Institute of Medicine in 2003 in recognition of his contribution to its work. He has chaired the National Academies’ Roundtable on Population Health Improvement and the Roundtable on Health Literacy; chaired, served, and been a reviewer for a number of consensus committee reports; and participated in a number of National Academies workshops. Dr. Isham has been active in health policy, serving as a former member of the Centers for Disease Control and Prevention’s (CDC) Task Force on Community Preventive Services, as a member of the Agency for Healthcare Research and Quality’s U. S. Preventive Services Task Force, and was a founding co-chair of the National Committee for Quality Assurance’s committee on performance measurement as well as a founding co-chair of the National Quality Forum’s Measurement Application Partnership. He is a founding member of the advisory board for the National Guideline Clearinghouse and has served on the Advisory Committee to the Director of CDC. Dr. Isham earned his Bachelor of Arts Degree in Zoology and Master of Science in Preventive Medicine/Administrative Medicine from the University of Wisconsin–Madison, and his Doctor of Medicine from the University of Illinois in Chicago. He completed his internship and residency in internal medicine at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin. Dr. Isham has clinical experience as a general medical officer in the U. S. Navy, in the general practice of internal medicine at the Freeport Clinic in Freeport, Illinois, and as a clinical assistant professor of medicine at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin. Ebony Boulware, M.D., M.P.H., is a Professor of Medicine, Chief of the Division of General Internal Medicine in the Department of Medicine, Vice Dean for Translational Science, and Associate Vice Chancellor for Translational Research in the School of Medicine at Duke University. She received an A.B. from Vassar College, an M.D. from Duke University, and a M.P.H. from the Johns Hopkins Bloomberg School of Public Health. Dr. Boulware is a general internist and a clinical epidemiologist. She attended medical school at Duke University, completed medical training as a resident and chief resident at the University of Maryland, and she completed a research fellowship at the Johns Hopkins University School of Medicine. She became a faculty member in the Johns Hopkins School of Medicine and Bloomberg School of 1 The members of the committee serve on the committee as individuals rather than as representatives of their respective organizations. C-1 PREPUBLICATION COPY: UNCORRECTED PROOFS

C-2 LEADING HEALTH INDICATORS Public Health in 2002, where she achieved the academic rank of Full Professor. In 2013, she was appointed Chief of the Division of General Internal Medicine in the Department of Medicine at Duke University. In 2015, she was appointed the inaugural Director of the Duke Clinical and Translational Science Institute, and she is the contact Principal Investigator for the Duke Clinical and Translational Science Award for Duke University. Dr. Boulware has devoted her scholarly career to studying mechanisms to improve the quality and equity of health care and health outcomes for patients and populations with chronic diseases such as chronic kidney disease and hypertension. As part of her work, she investigates the influence of attitudinal, social, and environmental contexts on health and health outcomes. She has maintained an active research portfolio throughout her career, funded by the National Institutes of Health, the Patient-Centered Outcomes Research Institute, the Health Resources and Services Administration, the Agency for Healthcare Research and Quality, and several foundations. She has published more than 120 manuscripts, and she has mentored numerous students, fellows, and faculty members in clinical research. Dr. Boulware frequently engages community members, patients, their family members, and other stakeholders to develop and implement relevant and sustainable interventions to improve health. Gilbert Gee, Ph.D., is a Professor in the Department of Community Health Sciences at the Fielding School of Public Health at the University of California, Los Angeles. He received his bachelor degree in neuroscience from Oberlin College, his doctorate in Health Policy and Management from the Johns Hopkins University, and postdoctoral training in sociology from Indiana University. His research focuses on the social determinants of health inequities of racial, ethnic, and immigrant minority populations using a multilevel and life course perspective. A primary line of his research focuses on conceptualizing and measuring racism discrimination, and in understanding how discrimination may be related to illness. He has also published more broadly on the topics of stress, neighborhoods, environmental exposures, occupational health, and on Asian American populations. Current projects include the study of discrimination; racial identity and obesity among emigrants from the Philippines; the relationship between student loans and illness; and toxic exposures among Asian American participants in National Health and Nutrition Examination Survey. His research has been honored with a group Merit Award from the National Institutes of Health for the development of a multicultural measures of discrimination for health surveys. In addition, he received two Scientific and Technical Achievement Awards from the Environmental Protection Agency for development of the Stress- Exposure-Disease Framework. Marthe R. Gold, M.D., M.P.H., is a Senior Scholar at The New York Academy of Medicine, and the Logan Professor Emeritus in the Department of Community Health and Social Medicine at the City University of New York Medical School. A graduate of the Tufts University School of Medicine and the Columbia School of Public Health, her clinical training is in family medicine. Dr. Gold has been a primary care provider in urban and rural underserved settings. She served as Senior Policy Adviser in the Office of the Assistant Secretary for Health in the Department of Health and Human Services from 1990 to 1996 where her focus was on financing of clinical preventive services, the economics and outcomes of public health programs, and health care reform. She directed the work of the Panel on Cost-Effectiveness in Health and Medicine, an expert panel whose report remains an influential guide to cost-effectiveness methodology for academic and policy uses. Her current work focuses on patient, public, and PREPUBLICATION COPY: UNCORRECTED PROOFS

APPENDIX C C-3 decision maker views on using economic and comparative effectiveness information to inform health policy. A member of the National Academy of Medicine, Dr. Gold served as chair of its Committee on Public Health Strategies to Improve Health (reports published 2010–2012) and has been a member of the Roundtable on Population Health Improvement since its inception. Sheri Johnson, Ph.D. is the Director of the Population Health Institute (PHI) at the University of Wisconsin–Madison, Visiting Associate Professor, and Acting Director, County Health Rankings & Roadmaps, and the Robert Wood Johnson Foundation Culture of Health Prize. For more than 25 years Dr. Johnson has dedicated her career to partnering with children, families, community organizations, and systems to advance health and well-being. Awed by the resilience of individuals and communities, she is motivated to remove unfair obstacles and conditions that create and perpetuate health inequities. Dr. Johnson completed undergraduate studies at Brown University, earned an M.A. and a Ph.D. in clinical psychology at Boston University, and served as a Clinical Fellow in Psychology at Harvard Medical School. She was previously the Director of Behavioral Health at Milwaukee Health Services, Inc., a federally qualified health center, and served as the Administrator and State Health Officer for the Wisconsin Division of Public Health. Immediately prior to joining the PHI, she was Associate Professor of Pediatrics at the Medical College of Wisconsin Center for Advancement of Underserved Children where she collaborated with diverse stakeholders to address a broad range of real-world problems. Paula Lantz, Ph.D., is the Associate Dean for academic affairs and a professor of public policy at the Ford School. She also holds an appointment as professor of health management and policy in the School of Public Health. Dr. Lantz, a social demographer, studies the role of public policy in improving population health. She currently directs the University of Michigan Policies for Action Research Hub, funded by the Robert Wood Johnson Foundation, which is engaged in a number of research projects investigating public policy approaches to reducing social inequities in health. Dr. Lantz is leading a project regarding the potential for and challenges associated with using social impact bonds to fund public–private partnerships aimed at improving population health. An elected member of the National Academy of Social Insurance and the National Academy of Medicine, Dr. Lantz received an M.A. in sociology from Washington University, St. Louis, and an M.S. in epidemiology and a Ph.D. in sociology from the University of Wisconsin. Darcy Phelan-Emrick, Dr.P.H., M.H.S., has served as Chief Epidemiologist at the Baltimore City Health Department since 2015. She leads the Health Department's efforts to develop and track public health objectives and goals. Dr. Phelan-Emrick has been a full-time faculty member in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health since 2009, and she holds a joint appointment in the Department of Health, Behavior and Society. She has held prior positions in the New York City Department of Health and Mental Hygiene, the New York Academy of Medicine, and Rockefeller University. Dr. Phelan-Emrick received her Dr.P.H. in 2009 and M.H.S. in 2005, both in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Jonathan S. Skinner, Ph.D., is a health economist with experience leading several research projects funded by the National Institute on Aging (NIA). These are large-scale interdisciplinary collaborations at Dartmouth and involving partner institutions, drawing on Dartmouth’s comprehensive Medicare and Medicaid datasets. Dr. Skinner’s ongoing research focuses on PREPUBLICATION COPY: UNCORRECTED PROOFS

C-4 LEADING HEALTH INDICATORS studying the contribution of “high-tech” health care to cost growth, the diffusion of various types of medical innovations (beneficial and less so), how provider networks affect technology diffusion, and measuring efficiency in health care. A member of the National Academy of Medicine, Dr. Skinner is also a research associate and director of the Aging Program at the National Bureau of Economic Research. He has taught in Dartmouth’s economics department since 1995, where he serves as the James O. Freedman Presidential Professor. PREPUBLICATION COPY: UNCORRECTED PROOFS

Next: Appendix D Criteria for Selecting a Set of Leading Health Indicators »
Criteria for Selecting the Leading Health Indicators for Healthy People 2030 Get This Book
×
Buy Paperback | $45.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Every ten years, the Department of Health and Human Service’s Healthy People Initiative develops a new set of science-based, national objectives with the goal of improving the health of all Americans. Defining balanced and comprehensive criteria for healthy people enables the public, programs, and policymakers to gauge our progress and reevaluate efforts towards a healthier society. Criteria for Selecting the Leading Health Indicators for Healthy People 2030 makes recommendations for the development of Leading Health Indicators for the initiative’s Healthy People 2030 framework. The authoring committee’s assessments inform their recommendations for the Healthy People Federal Interagency Workgroup in their endeavor to develop the latest Leading Health Indicators. The finalized Leading Health Indicators will establish the criteria for healthy Americans and help update policies that will guide decision-marking throughout the next decade. This report also reviews and reflects upon current and past Healthy People materials to identify gaps and new objectives.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!